Dr. Jason Karlawish, co-director of the Penn Memory Center, presents “The House of Alzheimer’s Disease” at the Max Planck Institute for Human Development in Berlin this week.
Over the weekend, Dr. Jason Karlawish, co-director of the Penn Memory Center, joined colleagues from the University of Cambridge at Fondation Brocher in Hermance, Switzerland, for “The redefinition of Alzheimer’s disease and its social and ethical consequences. His co-organizers included Research Associate Milne Richard and Senior Research Associate Badger Shirlene.
The event brought together social scientists and ethicists to “explore the boundary between the clinical and research uses of biomarkers and how, as this boundary shifts, it changes how we study, care for and, as a society, approach Alzheimer’s disease,” according to the event’s website.
From there, Karlawish flew to Berlin, where he presented “The House of Alzheimer’s Disease” as part of the Center for Lifespan Psychology Guest Colloquium at the Max Planck Institute for Human Development. Karlawish spoke on the same topic in March at Drexel University.